Biotech
CohBar Completes Last Subject Visit in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
MENLO PARK, Calif., April 21, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced that the last more...
Energy
Gevo to Report First Quarter 2021 Financial Results on May 13, 2021
ENGLEWOOD, Colo., April 21, 2021 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) announced today that it will host a conference call on Thursday, May 13, 2021 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for more...
Mining
Successful conclusion of consent process under the Lock-Up Agreement dated March 27, 2021
LONDON, April 21, 2021 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ: GSM) (the “Company”) refers to the Company’s release on March 28, 2021 regarding the lock-up agreement dated March 27, 2021 (the “Lock-Up Agreement”) between the more...
Tech
Turtle Beach Corporation To Report First Quarter 2021 Financial Results On Wednesday, May 5, 2021
Turtle Beach Corporation To Report First Quarter 2021 Financial Results On Wednesday, May 5, 2021 PR Newswire WHITE PLAINS, N.Y. , April 21, 2021 /PRNewswire/ — Turtle Beach Corporation (Nasdaq: HEAR), a leading gaming accessory business, more...
Tech
Leigh Dow, Identiv VP of Global Marketing, Honored with Top 25 Women Leaders in Cybersecurity Award
Leigh Dow, Identiv VP of Global Marketing, Honored with Top 25 Women Leaders in Cybersecurity Award Dow recognized for her contributions as a leader and mentor in the security industry PR Newswire FREMONT, Calif. , more...
Biotech
Mustang Bio to Participate in Chardan’s 5th Annual Genetic Medicines Manufacturing Summit
WORCESTER, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, more...
Biotech
Ayala Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of AL102 in Combination with BCMA Targeting Agent, WVT078, in Patients with relapsed/refractory Multiple Myeloma
REHOVOT, Israel and WILMINGTON, Del., April 21, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive more...
Biotech
Evofem Biosciences to Deliver Keynote Address and Present Two Phexxi Data Sets at NCODA 2021 National Spring Forum
Evofem Biosciences to Deliver Keynote Address and Present Two Phexxi Data Sets at NCODA 2021 National Spring Forum Posters Focus on Perfect-Use Efficacy Data and Sexual Satisfaction and Function Among Women in the Phase 3 more...
Health
New Publications Highlight Clinical Benefits of Avinger PAD Therapies
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease more...
Health
SeaSpine to Report First Quarter 2021 Financial Results on May 3, 2021
CARLSBAD, Calif., April 21, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release first more...